In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced insulin for months without the patient needing to take immunosuppressants.

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

Can genetic editing help improve the overall health of people living with type 1 diabetes? The results of a recent study ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...

Hybrid seed production is vital for enhancing crop yield and quality, yet conventional methods in rapeseed are limited by inefficiency and high ...

Researchers engineered a bespoke CRISPR-Cas9 gene-editing enzyme to develop a potential therapy for MSMDS, which ...